181 related articles for article (PubMed ID: 22219309)
1. Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species.
Conville PS; Brown-Elliott BA; Wallace RJ; Witebsky FG; Koziol D; Hall GS; Killian SB; Knapp CC; Warshauer D; Van T; Wengenack NL; Deml S; Woods GL
J Clin Microbiol; 2012 Apr; 50(4):1270-80. PubMed ID: 22219309
[TBL] [Abstract][Full Text] [Related]
2. [Antimicrobial susceptibilities of clinical Nocardia isolates identified by 16S rRNA gene sequence analysis].
Uner MC; Hasçelik G; Müştak HK
Mikrobiyol Bul; 2016 Jan; 50(1):11-20. PubMed ID: 27058325
[TBL] [Abstract][Full Text] [Related]
3.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923878
[TBL] [Abstract][Full Text] [Related]
4. [Comparative evaluation of e-test and disk diffusion methods for susceptibility testing of Nocardia species].
Perçin D; Sümerkan B; Inci R
Mikrobiyol Bul; 2011 Apr; 45(2):274-9. PubMed ID: 21644070
[TBL] [Abstract][Full Text] [Related]
5. Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China.
Wei M; Wang P; Qu J; Li R; Liu Y; Gu L; Yang C
J Glob Antimicrob Resist; 2017 Dec; 11():183-187. PubMed ID: 28870771
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic analysis of antimicrobial resistance in Nocardia species.
Hershko Y; Levytskyi K; Rannon E; Assous MV; Ken-Dror S; Amit S; Ben-Zvi H; Sagi O; Schwartz O; Sorek N; Szwarcwort M; Barkan D; Burstein D; Adler A
J Antimicrob Chemother; 2023 Sep; 78(9):2306-2314. PubMed ID: 37527397
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis.
McTaggart LR; Doucet J; Witkowska M; Richardson SE
Antimicrob Agents Chemother; 2015 Jan; 59(1):269-75. PubMed ID: 25348540
[TBL] [Abstract][Full Text] [Related]
8. Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species.
Lai CC; Liu WL; Ko WC; Chen YH; Tan HR; Huang YT; Hsueh PR
Antimicrob Agents Chemother; 2011 May; 55(5):2084-91. PubMed ID: 21343461
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility testing and profiling of Nocardia species and other aerobic actinomycetes from South Africa: comparative evaluation of broth microdilution versus the Etest.
Lowman W; Aithma N
J Clin Microbiol; 2010 Dec; 48(12):4534-40. PubMed ID: 20980572
[TBL] [Abstract][Full Text] [Related]
10. Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of clinical isolates of the Nocardia asteroides complex.
Ambaye A; Kohner PC; Wollan PC; Roberts KL; Roberts GD; Cockerill FR
J Clin Microbiol; 1997 Apr; 35(4):847-52. PubMed ID: 9157140
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility testing of Nocardia species for the clinical laboratory.
Wallace RJ; Steele LC
Diagn Microbiol Infect Dis; 1988 Mar; 9(3):155-66. PubMed ID: 3293892
[TBL] [Abstract][Full Text] [Related]
12. Identification and antimicrobial susceptibility of referred
Yeoh K; Globan M; Naimo P; Williamson DA; Lea K; Bond K
J Med Microbiol; 2022 Aug; 71(8):. PubMed ID: 35976092
[No Abstract] [Full Text] [Related]
13. Isolation and Characterization of Nocardia Species from Pulmonary Nocardiosis in a Tertiary Hospital in China.
Li J; Shen H; Yu T; Tao XY; Hu YM; Wang HC; Zou MX
Jpn J Infect Dis; 2022 Jan; 75(1):31-35. PubMed ID: 34053953
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antimicrobial susceptibility testing of Nocardia spp. isolates by broth microdilution with resazurin and spectrophotometry.
Caso Coelho V; Pereira Neves SD; Cintra Giudice M; Benard G; Lopes MH; Sato PK
BMC Microbiol; 2021 Dec; 21(1):331. PubMed ID: 34865615
[TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations and antimicrobial susceptibility of Nocardia species at a tertiary hospital in Taiwan, 2011-2020.
Lao CK; Tseng MC; Chiu CH; Chen NY; Chen CH; Chung WH; Liu TP; Lu JJ; Lai HC; Yang LY; Lee CH; Wu TS
J Formos Med Assoc; 2022 Oct; 121(10):2109-2122. PubMed ID: 35811270
[TBL] [Abstract][Full Text] [Related]
16. MLSA phylogeny and antimicrobial susceptibility of clinical Nocardia isolates: a multicenter retrospective study in China.
Wei M; Xu X; Yang J; Wang P; Liu Y; Wang S; Yang C; Gu L
BMC Microbiol; 2021 Dec; 21(1):342. PubMed ID: 34903163
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.
Lai CC; Tan CK; Lin SH; Liao CH; Chou CH; Hsu HL; Huang YT; Hsueh PR
J Antimicrob Chemother; 2009 Jul; 64(1):73-8. PubMed ID: 19398458
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility profiles and species distribution of medically relevant Nocardia species: Results from a large tertiary laboratory in Australia.
Tan YE; Chen SC; Halliday CL
J Glob Antimicrob Resist; 2020 Mar; 20():110-117. PubMed ID: 31400449
[TBL] [Abstract][Full Text] [Related]
19. Susceptibility profiles of Nocardia isolates based on current taxonomy.
Schlaberg R; Fisher MA; Hanson KE
Antimicrob Agents Chemother; 2014; 58(2):795-800. PubMed ID: 24247124
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of fluoroquinolones against clinical isolates of Nocardia identified by partial 16S rRNA sequencing.
Hansen G; Swanzy S; Gupta R; Cookson B; Limaye AP
Eur J Clin Microbiol Infect Dis; 2008 Feb; 27(2):115-20. PubMed ID: 17992548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
